Tumor regression grading is a system used to evaluate the extent of tumor response to treatment, particularly in neoadjuvant therapy, by examining the histopathological changes in the tumor tissue. It provides crucial prognostic information and helps guide subsequent treatment decisions based on the degree of tumor cell death and fibrosis observed.